Stryker (SYK) Asset Writedowns and Impairment (2010 - 2025)
Stryker's (SYK) quarterly Asset Writedowns and Impairment came in at $7.0 million in Q4 2025, down 99.27% year-on-year from $956.0 million in Q4 2024, and down 90.41% on a QoQ basis from $73.0 million in Q3 2025.
Stryker (SYK) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends
Stryker (SYK) has 10 years of Asset Writedowns and Impairment data on file, last reported at $7.0 million in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 99.27% year-over-year to $7.0 million in Q4 2025; TTM through Mar 2026 was $135.0 million, a 86.62% decrease from a year earlier, with the FY2025 full-year figure at $170.0 million, down 82.6% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $7.0 million, down from $73.0 million in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for SYK reached as high as $956.0 million in Q4 2024 and fell as low as $1.0 million in Q2 2023.
- Historically, Asset Writedowns and Impairment has averaged $111.9 million across 5 years, with a median of $29.5 million in 2023.
- Across the five-year window, Asset Writedowns and Impairment surged 3883.33% in 2024 and sank 99.27% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $145.0 million in 2021, then surged by 73.79% to $252.0 million in 2022, then slumped by 90.48% to $24.0 million in 2023, then jumped by 3883.33% to $956.0 million in 2024, then sank by 99.27% to $7.0 million in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $7.0 million in Q4 2025, $73.0 million in Q3 2025, and $55.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Sep 30, 2023 | 9.00 Mn |